symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ZVSA,0.1221,0,5538157,5313230,0,0.11-25.0,-0.0041,"ZyVersa Therapeutics, Inc.",USD,0001859007,,,NASDAQ Global Market,NASDAQ,Biotechnology,https://www.zyversa.com,"ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.",Mr. Stephen C. Glover,Healthcare,US,7,754 231 1688,2200 N. Commerce Parkway,Weston,FL,33326,,0,https://financialmodelingprep.com/image-stock/ZVSA.png,2022-02-11,False,False,True,False,False
